Assessing the Reversibility of Airway Obstruction

Chest

Volumn 114, Issue 6, 1998, Pages 1607-1612

  Pellegrino, Riccardo ^a   Rodarte, Joseph R ^b   Brusasco, Vito ^c,d  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

Author keywords

Asthma; COPD; Fev1; Functional residual capacity; Inspiratory capacity; Partial and maximal flow volume curves

Indexed keywords

BRONCHODILATING AGENT; SALBUTAMOL;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BREATHING MECHANICS; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AIRWAY OBSTRUCTION; ALBUTEROL; BRONCHODILATOR AGENTS; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RESPIRATORY MECHANICS;

EID: 0032253550     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.6.1607     Document Type: Article

References (28)

1. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218
2. Nadel JA, Tierney DF. Effect of a previous deep inspiration on airway resistance in man. J Appl Physiol 1961; 16:717-719
3. Barnes PJ, Gribbin HR, Osmanliev D, et al. Partial flow-volume curves to measure bronchodilator dose-response curves in normal humans. J Appl Physiol 1981; 50:1193-1197
4. Berry RB, Fairshter RD. Partial and maximal expiratory flow-volume curves in normal and asthmatic subjects before and after inhalation of metaproterenol. Chest 1985; 88:697-702
5. Wang JW, McFadden ER, Ingram RH Jr. Effects of increasing doses of β-agonists on airway and parenchymal hysteresis. J Appl Physiol 1990; 68:363-368
6. Pellegrino R, Brusasco V. Lung hyperinflation and flow limitation in chronic airway obstruction. Eur Respir J 1997; 10:543-549
7. Goldstein D, Mead J. Use of magnetometers to volume-reference flow-volume curves. J Appl Physiol 1980; 48:731-736
8. Eliasson O, Degraff AC Jr. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials: influence of clinical diagnosis, spirometric, and anthropometric variables. Am Rev Respir Dis 1985; 132:858-864
9. American Thoracic Society. Chronic bronchitis, asthma and pulmonary emphysema. Am Rev Respir Dis 1962; 84:762-768
10. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:5-40
11. Sourk RL, Nugent KM. Bronchodilator testing: confidence intervals derived from placebo inhalations. Am Rev Respir Dis 1983; 128:153-157
12. Krowka MJ, Enright PL, Rodarte JR, et al. Effect of effort on measurement of forced expiratory volume in one second. Am Rev Respir Dis 1987; 136:829-833
13. Nickerson BG, Lemen RJ, Gerdes CB, et al. Within-subject variability and the percent change for significance of spirometry in normal subjects and in patients with cystic fibrosis. Am Rev Respir Dis 1980; 122:859-866
14. Anthonisen NR, Wright EC, and the IPPB Trial Group. Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133:814-819
15. Brand PL, Quanjer PH, Postma DS, et al. Interpretation of bronchodilator response in patients with obstructive airways disease: The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax 1992; 47:429-436
16. 1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax 1987; 42;487-490
17. Weir DC, Burge PS. Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway calibre. Thorax 1991; 46:43-45
18. Dales RE, Spitzer WO, Tousignant P, et al. Clinical interpretation of airway response to a bronchodilator: epidemiologic considerations. Am Rev Respir Dis 1988; 138:317-320
19. Kirby JB, Juniper EF, Hargreave FE, et al. Total lung capacity does not change during methacholine-stimulated airway narrowing. J Appl Physiol 1986; 61:2144-2147
20. Pellegrino R, Wilson O, Jenouri G, et al. Lung mechanics during bronchoconstriction. 1996. J Appl Physiol 1996; 81: 964-975
21. Hughes JA, Tobin MJ, Bellamy D, et al. Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema. Thorax 1982; 37:667-670
22. Zinman R, Wohl MEB, Ingram RH Jr. Nonhomogeneous lung emptying in cystic fibrosis patients: volume history and bronchodilator effects. Am Rev Respir Dis 1991; 143:1257-1261
23. Froeb HF, Mead J. Relative hysteresis of the dead space and lung in vivo. J Appl Physiol 1968; 25:244-248
24. Sasaki H, Hoppin FG Jr. Hysteresis of contracted airway smooth muscle. J Appl Physiol 1979; 47:1251-1262
25. Gibbons WJ, Sharma A, Lougheed D, et al. Detection of excessive bronchoconstriction in asthma. Am J Respir Grit Care Med 1996; 153:582-589
26. Ingram RH Jr, Pedley TJ. Pressure-flow relationships in the lungs. In: Macklem PT, Mead J, eds. Handbook of Physiology. Section 3, vol. III, part 1: The respiratory system. Mechanics of breathing. Bethesda, MD: American Physiological Society, 1986; 277-293
27. Pellegrino R, Violante B, Nava S, et al. Expiratory airflow limitation and hyperinflation during methacholine-induced bronchoconstriction. J Appl Physiol 1993; 75:1720-1727
28. Pride NB, Macklem PT. Lung mechanics in disease. In: Macklem PT, Mead J, eds. Handbook of Physiology. Section 3, vol. III, part 2. The respiratory system. Mechanics of breathing. Bethesda, MD: American Physiological Society, 1986; 659-692